SCHEMBL434277

SCHEMBL434277

CN(C)S(=O)(=O)c1ccc(C2(C(=O)NC(CN3CCCC3)c3ccccc3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HTT P42858 2/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
PKM P14618 1/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALOX15 P16050 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CCR5 P51681 1/20 0.42
NPY2R P49146 1/20 0.41
OPRK1 P41145 6/20 0.41
OPRM1 P35372 3/20 0.41
OPRD1 P41143 3/20 0.41
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10083025 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EHTTHPGDKMT2A
SCHEMBL10083327 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EHTTHPGDKMT2A
SCHEMBL435448 0.89 CCR2 (0.43) ALDH1A1GAACYP2D6CCR5OPRK1
SCHEMBL10083346 0.89 CCR2 (0.43) ALDH1A1GAACYP2D6CCR5OPRK1
SCHEMBL15385513 0.88 GAA (0.50) ALDH1A1KDM4EHTTGAAGPR88
SCHEMBL432776 0.88 GAA (0.50) ALDH1A1KDM4EHTTGAAGPR88
SCHEMBL435831 0.85 HSD11B1 (0.50) ALDH1A1HTTKMT2AMEN1GAA
SCHEMBL15385492 0.85 HSD11B1 (0.50) ALDH1A1HTTKMT2AMEN1GAA
SCHEMBL15380543 0.84 OPRK1 (0.44) ALDH1A1KDM4EHPGDCYP2D6OPRK1
SCHEMBL10084049 0.84 OPRK1 (0.44) ALDH1A1KDM4EHPGDCYP2D6OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US claimed
WO-2012012410-A2 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES LTD. (IN) 2012-01-26 WO claimed
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed
WO-2012012410-A2 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES LTD. (IN) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS OPRK1, OPRL1, OPRD1 ALDH1A1 1649/4885KDM4E 1394/4885HTT 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.